Reckitt Benckiser Group plc Faces Class Action Lawsuit
Levi & Korsinsky, LLP has taken significant steps to inform investors about a class action lawsuit concerning Reckitt Benckiser Group plc, also known as Reckitt Benckiser Group plc (OTC PINK: RBGLY). This lawsuit has arisen due to allegations of securities fraud affecting shareholders.
Overview of the Class Action
The lawsuit is designed to recover losses for investors of Reckitt Benckiser who have been impacted by claimed securities fraud occurring between January 13, 2021, and July 28, 2024. It aims to address the financial damages that serious allegations can cause to investors.
What Constitutes Securities Fraud?
Securities fraud involves misleading information or deceptive practices that violate securities laws. In this case, the accusations state that Reckitt Benckiser executives allegedly made false statements about their products, potentially jeopardizing the safety of their infant formula, Enfamil. If these claims prove true, many investors could face significant financial loss due to the fall in stock value.
Allegations in Detail
The filed complaint alleges serious concerns regarding Reckitt's cow's milk-based formula. The core allegations state that the company concealed relevant facts that preterm infants face increased risks of developing necrotizing enterocolitis (NEC) when consuming this formula. Moreover, the company is said to have downplayed how these claims would impact sales and expose Reckitt to legal disputes.
Implications for Investors
The repercussions of such allegations can drastically influence stock prices. Investors who held shares during the aforementioned period may find themselves entitled to compensation should the court rule in favor of the class. Those impacted are encouraged to respond promptly, as there are formal deadlines for taking action in this context.
Next Steps for Affected Investors
If you have experienced a loss regarding your investment in Reckitt Benckiser during this time frame, now is the time to act. You have until August 4, 2025, to ask the court to be designated as lead plaintiff. However, it's important to know that you need not be the lead plaintiff to be eligible for recovery from any potential settlement.
No Financial Obligation
The participation in this lawsuit comes at no cost to you if you qualify as a class member. There are no out-of-pocket expenses involved, and there’s absolutely no obligation to join the lawsuit, which makes this a risk-free opportunity for those affected.
Why Choose Levi & Korsinsky?
Levi & Korsinsky has built a strong reputation over the past two decades, having successfully secured substantial compensation for investors in complex securities cases. With a skilled team comprising over 70 professionals ready to assist, clients can be confident in the firm’s ability to navigate the complexities of securities litigation. The team’s consistent recognition as one of the top firms in the United States speaks to their expertise and effectiveness in this field.
Contact Information
For further inquiries or assistance regarding your rights as an investor in this lawsuit, reach out to Levi & Korsinsky, LLP:
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
Tel: (212) 363-7500
Fax: (212) 363-7171
Frequently Asked Questions
What is the class action lawsuit about?
The lawsuit centers on alleged securities fraud by Reckitt Benckiser, impacting investors negatively.
How can I participate in the class action?
Investors can join by contacting Levi & Korsinsky before the deadline on August 4, 2025.
Are there any costs to join the lawsuit?
No, there are no costs or obligations for class members to participate in the lawsuit.
What are the allegations against Reckitt Benckiser?
The allegations suggest that the company misled investors regarding the safety of its infant formula products.
Why should I trust Levi & Korsinsky?
Levi & Korsinsky has a proven track record, securing substantial settlements and recognized as a leader in securities litigation.
